BEUDAMED
    FDA Adverse Event Injury Summary report: N

    LAP-BAND SYSTEM 10CM

    MDR report key: 6022690 · Received October 12, 2016

    Report

    Report Number
    3006722112-2016-00301
    Event Type
    Injury
    Date Received
    October 12, 2016
    Date of Event
    August 1, 2007
    Report Date
    October 12, 2016
    Manufacturer
    APOLLO ENDOSURGERY, INC.
    Product Code
    LTI
    PMA / PMN Number
    P000008
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Occupation
    PATIENT

    Narratives

    Additional Manufacturer Narrative · 1

    TAPER II. DEVICE EVALUATION SUMMARY: THE DEVICE WAS RETURNED TO APOLLO FOR ANALYSIS, AND VISUAL EXAMINATION CONFIRMED THE CONNECTOR TYPE AS TAPER II. BROWN PARTICLES WERE OBSERVED ON THE INNER SURFACE OF THE SHELL. YELLOW DISCOLORATION WAS OBSERVED ON THE LAP-BAND TUBING, PORT TUBING, AND ACCESS PORT TAPER. A PORT LEAK TEST WAS PERFORMED AND NO LEAKAGE WAS OBSERVED. AN AIR LEAK TEST WAS PERFORMED AND NO LEAKAGE WAS OBSERVED. A FILL TEST WAS PERFORMED AND NO BLOCKAGE OR RESISTANCE TO FLOW WAS OBSERVED. UNDER MICROSCOPIC ANALYSIS NON-PENETRATING NICKS WERE OBSERVED ON THE BUCKLE STRAP. ANALYSIS IDENTIFIED STRIATED MARKS ON THE BAND TUBING END, CONSISTENT WITH DEVICE REMOVAL. THE EVENTS REPORTED ARE SURGICAL/PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST APOLLO IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT.

    Additional Manufacturer Narrative · 1

    UNKNOWN TAPER. MEDWATCH WAS SENT TO THE FDA ON 10/12/2016. THIS EVENT WAS REPORTED BY THE PATIENT. TO DATE, APOLLO HAS BEEN UNABLE TO CONFIRM THE REPORTED EVENTS WITH THE PATIENT'S PHYSICIAN. DEVICE LABELING ADDRESSES THE REPORTED EVENTS AS FOLLOWS: ADVERSE EVENTS: IT IS IMPORTANT TO DISCUSS ALL POSSIBLE COMPLICATIONS AND ADVERSE EVENTS WITH YOUR PATIENT. COMPLICATIONS WHICH MAY RESULT FROM THE USE OF THIS PRODUCT INCLUDE THE RISKS ASSOCIATED WITH THE MEDICATIONS AND METHODS UTILIZED IN THE SURGICAL PROCEDURE, THE RISKS ASSOCIATED WITH ANY SURGICAL PROCEDURE AND THE PATIENT'S DEGREE OF INTOLERANCE TO ANY FOREIGN OBJECT IMPLANTED IN THE BODY ULCERATION, GASTRITIS, GASTROESOPHAGEAL REFLUX, HEARTBURN, GAS BLOAT, DYSPHAGIA, DEHYDRATION, CONSTIPATION, AND WEIGHT REGAIN HAVE BEEN REPORTED AFTER GASTRIC RESTRICTION PROCEDURES. ESOPHAGEAL DISTENSION OR DILATATION HAS BEEN INFREQUENTLY REPORTED. THIS IS MOST LIKELY A CONSEQUENCE OF INCORRECT BAND PLACEMENT, OVER-RESTRICTION OR STOMA OBSTRUCTION. IT CAN ALSO BE DUE TO EXCESSIVE VOMITING OR PATIENT NONCOMPLIANCE, AND MAY BE MORE LIKELY IN CASES OF PRE-EXISTING ESOPHAGEAL DYSMOTILITY. DEFLATION OF THE BAND IS RECOMMENDED IF ESOPHAGEAL DILATATION DEVELOPS. A REVISION PROCEDURE MAY BE NECESSARY TO REPOSITION OR REMOVE THE BAND IF DEFLATION DOES NOT RESOLVE THE DILATATION. NAUSEA AND VOMITING MAY OCCUR, PARTICULARLY IN THE FIRST FEW DAYS AFTER SURGERY AND WHEN THE PATIENT EATS MORE THAN RECOMMENDED. NAUSEA AND VOMITING MAY ALSO BE SYMPTOMS OF STOMA OBSTRUCTION OR A BAND/ STOMACH SLIPPAGE. FREQUENT, SEVERE VOMITING CAN RESULT IN POUCH DILATATION, STOMACH SLIPPAGE OR ESOPHAGEAL DILATATION. DEFLATION OF THE BAND IS IMMEDIATELY INDICATED IN ALL OF THESE SITUATIONS. DEFLATION OF THE BAND MAY ALLEVIATE EXCESSIVELY RAPID WEIGHT LOSS AND NAUSEA AND VOMITING. REOPERATION TO REPOSITION OR REMOVE THE DEVICE MAY BE REQUIRED. OTHER ADVERSE EVENTS CONSIDERED RELATED TO THE LAP-BAND SYSTEM THAT OCCURRED IN FEWER THAN 1% OF SUBJECTS INCLUDED: ESOPHAGITIS, GASTRITIS, HIATAL HERNIA, PANCREATITIS, ABDOMINAL PAIN, HERNIA, INCISIONAL INFECTION, INFECTION, REDUNDANT SKIN, DEHYDRATION, GI PERFORATION, DIARRHEA, ABNORMAL STOOLS, CONSTIPATION, FLATULENCE, DYSPEPSIA, ERUCTATION, CARDIOSPASM, HEMATEMESIS, ASTHENIA, FEVER, CHEST PAIN, INCISION PAIN, CONTACT DERMATITIS, ABNORMAL HEALING, EDEMA, PARESTHESIA, DYSMENORRHEA, HYPOCHROMIC ANEMIA, BAND LEAK, CHOLECYSTITIS, ESOPHAGEAL DYSMOTILITY, ESOPHAGEAL ULCER, ESOPHAGITIS, PORT DISPLACEMENT, PORT SITE PAIN, SPLEEN INJURY AND WOUND INFECTION. WARNINGS: PATIENTS SHOULD BE ADVISED THAT THE LAP-BAND AP SYSTEM IS A LONG-TERM IMPLANT. EXPLANT (REMOVAL) AND REPLACEMENT SURGERY MAY BE INDICATED AT ANY TIME. MEDICAL MANAGEMENT OF ADVERSE REACTIONS MAY INCLUDE EXPLANTATION. REVISION SURGERY FOR EXPLANTATION AND REPLACEMENT MAY ALSO BE INDICATED TO ACHIEVE PATIENT SATISFACTION.

    Description of Event or Problem · 1

    ADDITIONAL INFORMATION PROVIDED BY THE DOCTOR'S OFFICE, "PATIENT WAS SUCCESSFUL IN LOSING WEIGHT AT THE BEGINNING, HOWEVER EVERY TIME AFTER A FILL THE PATIENT WOULD EXPERIENCE REFLUX. BY 2011 THE PHYSICIAN DECIDED TO EMPTY THE BAND. IN THE PATIENT'S NOTES IT WAS REPORTED THAT THE PATIENT HAD NAUSEA, VOMITING, DYSPHAGIA, CHEST PAIN, MILD GASTRITIS AND BLOATING. AN UPPER GI DID NOTE THERE WAS POSSIBLY BAND RESTRICTION ISSUES."

    Description of Event or Problem · 1

    REPORTED AS: A PATIENT WITH THE LAP-BAND SYSTEM WAS REPORTED TO HAVE INTERMITTENT VOMITING, A HIATAL HERNIA, BULGING OF THE ESOPHAGUS, AND MALLORY WEISS SYNDROME. THE PATIENT STATED THEY "HAD CONTINUALLY HAD ISSUES OVER THE YEARS" AND "CONTINUALLY ASKED TO HAVE THE BAND REMOVED." THE PATIENT REPORTEDLY WENT FROM "(B)(6) DOWN TO (B)(6) AND IS CURRENTLY (B)(6)." THE DEVICE HAS BEEN EXPLANTED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    673171 LAP-BAND SYSTEM 10CM ADJUSTABLE GASTRIC BAND LTI APOLLO ENDOSURGERY, INC. B-2220 NI

    Patients

    Seq Age Sex Outcome Treatment
    1 47 YR Required Intervention